Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

GH secretagogues for osteoporosis

Sep. 19, 1997

PTH analogue restores bone mass in rabbits with glucocorticoid-induced osteopenia

Sep. 19, 1997

Lilly describes another SERM derived from raloxifene

Sep. 19, 1997

Mitsubishi comes up with a new conjugate of 17beta-estradiol and a bisphosphonate

Sep. 19, 1997

Antidiabetic activity of beta3-adrenoceptor agonist BRL-37344 elucidated in vitro

Sep. 19, 1997

U.S. introduction for FemPatch

Sep. 18, 1997

Dopamine D1/D2 coactivation maximizes metabolic responses in obese mice

Sep. 18, 1997

TheraTech and Astra sign agreement for Androderm distribution

Sep. 18, 1997

New raloxifene analogue from Lilly is a potent SERM

Sep. 18, 1997

Novel osteoclast resorption inhibitor isolated by Swiss investigators

Sep. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...